MHP
CATX icon

Manatuck Hill Partners’s Perspective Therapeutics CATX Stock Holding History

Manatuck Hill Partners’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-60,000
Closed -$1.87M – 107
2014
Q2 		$1.87M Buy
+60,000
New +$1.5M 0.32% 55

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Manatuck Hill Partners's CATX Position: Q3 2014 in Review

Manatuck Hill Partners sold out of Perspective Therapeutics (CATX) in Q3 2014, closing a stake of 60,000 shares — an estimated $1.87M sold.

Manatuck Hill Partners first reported a position in CATX in Q2 2014 and held it in 1 quarter. The position peaked at $1.87M in Q2 2014. 27 funds tracked by Wall St. Rank hold CATX as of Q3 2014.

  • Manatuck Hill Partners reported no remaining Perspective Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Manatuck Hill Partners sold 60,000 Perspective Therapeutics shares in Q3 2014, an estimated $1.87M.
  • Manatuck Hill Partners first reported a position in Perspective Therapeutics in Q2 2014 and held it in 1 quarter.
  • Manatuck Hill Partners's Perspective Therapeutics position peaked at $1.87M in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2014.

Based on Manatuck Hill Partners's 13F filing for Q3 2014, filed 14 Nov 2014.